Naphazoline / pheniramine
Allergy · OTC
OTCAllergyDecongestant
| Strength | Naphazoline 0.025% / pheniramine 0.3% |
|---|---|
| Typical quantity | 15 mL bottle, OTC |
| Cash cost / month | Low · ~$0-20 |
| Drug class | Decongestant + antihistamine (combination) |
| Mechanism of action | Alpha-adrenergic vasoconstrictor plus first-generation H1-antagonist. |
| Indication / reason for use | Short-term relief of redness and itching from allergic conjunctivitis. |
| Usual adult dosing | 1 drop up to 4×/day for no more than ~3 days. |
| Preservative | BAK |
| Contact lenses | Remove lenses before use. |
| Common / important adverse effects | Rebound hyperemia (conjunctivitis medicamentosa) with overuse, mydriasis, stinging, raised IOP. |
| Contraindications & cautions | Narrow angles / untreated angle-closure risk; caution with cardiovascular disease, hypertension, MAOIs; children <6 y. |
| Pregnancy / lactation | Avoid routine use; limited data. |
| Trade names | Naphcon-A, Visine-A, Opcon-A |
| Practice notes | Counsel firmly against chronic use because of rebound redness. |
Chair-side reference only. Dosing, contraindications and pregnancy guidance here are not exhaustive. Confirm against the current prescribing information and the patient’s full history before prescribing or advising.